| Vector-borne diseases World Health Organization Vector-borne diseases, 2014 | 938* | 2014 |
| A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms D Ménard, N Khim, J Beghain, AA Adegnika, M Shafiul-Alam, O Amodu, ... New England Journal of Medicine 374 (25), 2453-2464, 2016 | 597 | 2016 |
| Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia S Takala-Harrison, CG Jacob, C Arze, MP Cummings, JC Silva, ... The Journal of infectious diseases 211 (5), 670-679, 2015 | 480 | 2015 |
| A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness S Ahmed, MM Karim, AG Ross, MS Hossain, JD Clemens, MK Sumiya, ... International Journal of Infectious Diseases 103, 214-216, 2021 | 344 | 2021 |
| Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin: a double-blind, randomized, controlled trial WA Khan, C Seas, U Dhar, MA Salam, ML Bennish Annals of internal medicine 126 (9), 697-703, 1997 | 239 | 1997 |
| Single-dose azithromycin for the treatment of cholera in adults D Saha, MM Karim, WA Khan, S Ahmed, MA Salam, ML Bennish New England Journal of Medicine 354 (23), 2452-2462, 2006 | 198 | 2006 |
| Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach NTT Do, HTL Vu, CTK Nguyen, S Punpuing, WA Khan, M Gyapong, ... The Lancet Global Health 9 (5), e610-e619, 2021 | 197 | 2021 |
| Antimicrobial resistance: an antimicrobial/diagnostic stewardship and infection prevention approach EJ Septimus Medical Clinics 102 (5), 819-829, 2018 | 179 | 2018 |
| A framework for global surveillance of antibiotic resistance H Grundmann, KP Klugman, T Walsh, P Ramon-Pardo, B Sigauque, ... Drug Resistance Updates 14 (2), 79-87, 2011 | 175 | 2011 |
| Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets B Stefanska, D Cheishvili, M Suderman, A Arakelian, J Huang, M Hallett, ... Clinical Cancer Research 20 (12), 3118-3132, 2014 | 165 | 2014 |
| Treatment of shigellosis: III. Comparison of one-or two-dose ciprofloxacin with standard 5-day therapy: a randomized, blinded trial ML Bennish, MA Salam, WA Khan, AM Khan Annals of internal medicine 117 (9), 727-734, 1992 | 157 | 1992 |
| Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae O1 or O139 WA Khan, ML Bennish, C Seas, EH Khan, A Ronan, U Dhar, W Busch, ... The Lancet 348 (9023), 296-300, 1996 | 124 | 1996 |
| The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta … RJ Commons, JA Simpson, K Thriemer, GS Humphreys, T Abreha, ... The Lancet Infectious Diseases 18 (9), 1025-1034, 2018 | 117 | 2018 |
| Malaria prevalence in endemic districts of Bangladesh U Haque, SM Ahmed, S Hossain, M Huda, A Hossain, MS Alam, ... PloS one 4 (8), e6737, 2009 | 115 | 2009 |
| Central nervous system manifestations of childhood shigellosis: prevalence, risk factors, and outcome WA Khan, U Dhar, MA Salam, JK Griffiths, TMW Rand, ML Bennish Pediatrics 103 (2), e18-e18, 1999 | 113 | 1999 |
| Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis MA Salam, U Dhar, WA Khan, ML Bennish The Lancet 352 (9127), 522-527, 1998 | 112 | 1998 |
| Cause-specific mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites PK Streatfield, WA Khan, A Bhuiya, N Alam, A Sié, AB Soura, B Bonfoh, ... Global health action 7 (1), 25362, 2014 | 111 | 2014 |
| Transferable Quinolone Resistance in Vibrio cholerae HB Kim, M Wang, S Ahmed, CH Park, RC LaRocque, ASG Faruque, ... Antimicrobial agents and chemotherapy 54 (2), 799-803, 2010 | 108 | 2010 |
| Gastrointestinal and Extra-Intestinal Manifestations of Childhood Shigellosis in a Region Where All Four Species of Shigella Are Endemic WA Khan, JK Griffiths, ML Bennish PloS one 8 (5), e64097, 2013 | 106 | 2013 |
| Antiplasmodial activity of flavonol quercetin and its analogues in Plasmodium falciparum: evidence from clinical isolates in Bangladesh and standardized parasite … D Ganesh, HP Fuehrer, P Starzengrüber, P Swoboda, WA Khan, ... Parasitology Research 110, 2289-2295, 2012 | 99 | 2012 |